Increased excitation-inhibition balance due to a loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction

There is substantial evidence that both NMDA receptor (NMDAR) hypofunction and dysfunction of GABAergic neurotransmission contribute to schizophrenia, though the relationship between these pathophysiological processes remains largely unknown. While models using cell-type-specific genetic deletion of NMDARs have been informative, they display overly pronounced phenotypes extending beyond those of schizophrenia. Here, we used the serine racemase knockout (SRKO) mice, a model of reduced NMDAR activity rather than complete receptor elimination, to examine the link between NMDAR hypofunction and decreased GABAergic inhibition. The SRKO mice, in which there is a >90% reduction in the NMDAR co-agonist D-serine, exhibit many of the neurochemical and behavioral abnormalities observed in schizophrenia. We found a significant reduction in inhibitory synapses onto CA1 pyramidal neurons in the SRKO mice. This reduction increases the excitation/inhibition balance resulting in enhanced synaptically-driven neuronal excitability and elevated broad-spectrum oscillatory activity in ex vivo hippocampal slices. Consistently, significant reductions in inhibitory synapse density in CA1 were observed by immunohistochemistry. We further show, using a single-neuron genetic deletion approach, that the loss of GABAergic synapses onto pyramidal neurons observed in the SRKO mice is driven in a cell-autonomous manner following the deletion of SR in individual CA1 pyramidal cells. These results support a model whereby NMDAR hypofunction in pyramidal cells disrupts GABAergic synapse development leading to disrupted feedback inhibition and impaired neuronal synchrony.

[1]  J. Belforte,et al.  Early NMDA Receptor Ablation in Interneurons Causes an Activity-Dependent E/I Imbalance in vivo in Prefrontal Cortex Pyramidal Neurons of a Mouse Model Useful for the Study of Schizophrenia. , 2021, Schizophrenia bulletin.

[2]  J. Billard,et al.  Serine Racemase Deletion Affects the Excitatory/Inhibitory Balance of the Hippocampal CA1 Network , 2020, International journal of molecular sciences.

[3]  J. Coyle,et al.  Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction , 2020, Scientific Reports.

[4]  J. Coyle,et al.  Postsynaptic Serine Racemase Regulates NMDA Receptor Function , 2020, The Journal of Neuroscience.

[5]  D. Javitt,et al.  Translational neurophysiological biomarkers of N-methyl-d-aspartate receptor dysfunction in serine racemase knockout mice , 2020, bioRxiv.

[6]  C. Zold,et al.  Interneuron NMDA Receptor Ablation Induces Hippocampus-Prefrontal Cortex Functional Hypoconnectivity after Adolescence in a Mouse Model of Schizophrenia , 2020, The Journal of Neuroscience.

[7]  K. Nakazawa,et al.  The origin of NMDA receptor hypofunction in schizophrenia. , 2020, Pharmacology & therapeutics.

[8]  J. Rubenstein,et al.  Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders , 2019, Molecular Psychiatry.

[9]  D. Feldman,et al.  Increased Excitation-Inhibition Ratio Stabilizes Synapse and Circuit Excitability in Four Autism Mouse Models , 2018, Neuron.

[10]  W. Lu,et al.  Genetic deletion of NMDA receptors suppresses GABAergic synaptic transmission in two distinct types of central neurons , 2018, Neuroscience Letters.

[11]  Brian R. Lee,et al.  Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method , 2018, Journal of visualized experiments : JoVE.

[12]  J. A. Gray,et al.  Long-Term Depression Is Independent of GluN2 Subunit Composition , 2018, The Journal of Neuroscience.

[13]  K. Ressler,et al.  Serine Racemase and D-serine in the Amygdala Are Dynamically Involved in Fear Learning , 2018, Biological Psychiatry.

[14]  Zachary B. Loris,et al.  Enhanced astrocytic D-serine underlies synaptic damage after traumatic brain injury , 2017, The Journal of clinical investigation.

[15]  A. Grace,et al.  Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia , 2017, Molecular Psychiatry.

[16]  J. Glausier,et al.  GABA and schizophrenia: Where we stand and where we need to go , 2017, Schizophrenia Research.

[17]  K. Nakazawa,et al.  Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia , 2017, npj Schizophrenia.

[18]  J. Coyle,et al.  The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis , 2016, Trends in Neurosciences.

[19]  V. Sohal How Close Are We to Understanding What (if Anything) γ Oscillations Do in Cortical Circuits? , 2016, The Journal of Neuroscience.

[20]  T. Weickert,et al.  Biological Psychology : Stress , 2016 .

[21]  S. Anderson,et al.  D-Serine and Serine Racemase Are Associated with PSD-95 and Glutamatergic Synapse Stability , 2016, Front. Cell. Neurosci..

[22]  W. Lu,et al.  An NMDA Receptor-Dependent Mechanism Underlies Inhibitory Synapse Development. , 2016, Cell reports.

[23]  K. Deisseroth,et al.  Prefrontal Parvalbumin Neurons in Control of Attention , 2016, Cell.

[24]  J. Coyle,et al.  An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia , 2016, Neuropsychopharmacology.

[25]  L. Dobrunz,et al.  Interneuron Transcriptional Dysregulation Causes Frequency-Dependent Alterations in the Balance of Inhibition and Excitation in Hippocampus , 2015, The Journal of Neuroscience.

[26]  Renee Hoch,et al.  Gamma Rhythms Link Prefrontal Interneuron Dysfunction with Cognitive Inflexibility in Dlx5/6 +/− Mice , 2015, Neuron.

[27]  Rachel S White,et al.  Pyramidal Cell Selective Ablation of N-Methyl-D-Aspartate Receptor 1 Causes Increase in Cellular and Network Excitability , 2015, Biological Psychiatry.

[28]  E. Kavalali The mechanisms and functions of spontaneous neurotransmitter release , 2014, Nature Reviews Neuroscience.

[29]  Raquel E. Gur,et al.  Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia , 2014, Molecular Psychiatry.

[30]  J. Coyle,et al.  Chronic D-serine reverses arc expression and partially rescues dendritic abnormalities in a mouse model of NMDA receptor hypofunction , 2014, Neurochemistry International.

[31]  S. Snyder,et al.  Serine Racemase Regulated by Binding to Stargazin and PSD-95 , 2014, The Journal of Biological Chemistry.

[32]  Y. T. Wang,et al.  The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse , 2014, Front. Cell. Neurosci..

[33]  J. Coyle,et al.  d-Serine and Serine Racemase are Localized to Neurons in the Adult Mouse and Human Forebrain , 2014, Cellular and Molecular Neurobiology.

[34]  S. Barrow,et al.  MHCI Requires MEF2 Transcription Factors to Negatively Regulate Synapse Density during Development and in Disease , 2013, The Journal of Neuroscience.

[35]  S. Snyder,et al.  d-Serine in Glia and Neurons Derives from 3-Phosphoglycerate Dehydrogenase , 2013, The Journal of Neuroscience.

[36]  Stefan Kasicki,et al.  A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo , 2013, Journal of psychopharmacology.

[37]  J. Coyle,et al.  Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction , 2013, Proceedings of the National Academy of Sciences.

[38]  Bernardo L. Sabatini,et al.  Excitatory/Inhibitory Synaptic Imbalance Leads to Hippocampal Hyperexcitability in Mouse Models of Tuberous Sclerosis , 2013, Neuron.

[39]  Mark Ellisman,et al.  The Cell-Autonomous Role of Excitatory Synaptic Transmission in the Regulation of Neuronal Structure and Function , 2013, Neuron.

[40]  S. Siegel,et al.  Knockout of NMDA Receptors in Parvalbumin Interneurons Recreates Autism‐Like Phenotypes , 2013, Autism research : official journal of the International Society for Autism Research.

[41]  G. McCarthy,et al.  Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans , 2012, Molecular Psychiatry.

[42]  Yuko Fujita,et al.  Decreased susceptibility to seizures induced by pentylenetetrazole in serine racemase knockout mice , 2012, Epilepsy Research.

[43]  J. Coyle NMDA receptor and schizophrenia: a brief history. , 2012, Schizophrenia bulletin.

[44]  S. Siegel,et al.  Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia? , 2012, Genes, brain, and behavior.

[45]  A. Stan,et al.  Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. , 2012, Current pharmaceutical biotechnology.

[46]  Masahiko Watanabe,et al.  NMDA Receptors in GABAergic Synapses during Postnatal Development , 2012, PloS one.

[47]  Anthony J. Rissling,et al.  Hierarchical Organization of Gamma and Theta Oscillatory Dynamics in Schizophrenia , 2012, Biological Psychiatry.

[48]  Viktoriya D. Nikolova,et al.  Preweaning Sensorimotor Deficits and Adolescent Hypersociability in Grin1 Knockdown Mice , 2012, Developmental Neuroscience.

[49]  D. Bannerman,et al.  GluN1 hypomorph mice exhibit wide-ranging behavioral alterations , 2012, Genes, brain, and behavior.

[50]  S. Siegel,et al.  NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia , 2012, Neurobiology of Disease.

[51]  H. M. Morris,et al.  Lamina- and cell-specific alterations in cortical somatostatin receptor 2 mRNA expression in schizophrenia , 2012, Neuropharmacology.

[52]  J. Coyle,et al.  Cell Selective Conditional Null Mutations of Serine Racemase Demonstrate a Predominate Localization in Cortical Glutamatergic Neurons , 2012, Cellular and Molecular Neurobiology.

[53]  D. Lewis,et al.  NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. , 2012, Schizophrenia bulletin.

[54]  J. Coyle,et al.  The NMDA receptor co-agonists, d-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex , 2012, Neurobiology of Disease.

[55]  R. Nicoll,et al.  Distinct Modes of AMPA Receptor Suppression at Developing Synapses by GluN2A and GluN2B: Single-Cell NMDA Receptor Subunit Deletion In Vivo , 2011, Neuron.

[56]  S. Nelson,et al.  A Resource of Cre Driver Lines for Genetic Targeting of GABAergic Neurons in Cerebral Cortex , 2011, Neuron.

[57]  D. Lewis,et al.  GABA Neuron Alterations, Cortical Circuit Dysfunction and Cognitive Deficits in Schizophrenia , 2011, Neural plasticity.

[58]  Masahiko Watanabe,et al.  NMDA Receptors in Hippocampal GABAergic Synapses and Their Role in Nitric Oxide Signaling , 2011, The Journal of Neuroscience.

[59]  Jessica A. Cardin,et al.  A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior , 2011, Molecular Psychiatry.

[60]  R. Semba,et al.  Localization of d-serine and serine racemase in neurons and neuroglias in mouse brain , 2011, Neurological Sciences.

[61]  H. Eichenbaum,et al.  Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology , 2011, Genes, brain, and behavior.

[62]  J. Coyle,et al.  Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers , 2011, Neuroscience Letters.

[63]  Hannah Monyer,et al.  NMDA Receptor Ablation on Parvalbumin-Positive Interneurons Impairs Hippocampal Synchrony, Spatial Representations, and Working Memory , 2010, Neuron.

[64]  M. Buuse Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects , 2010 .

[65]  S. Oliet,et al.  Long term potentiation depends on release of D-serine from astrocytes , 2009, Nature.

[66]  R. Gur,et al.  Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia , 2009, Genes, brain, and behavior.

[67]  T. Sejnowski,et al.  Cortical Enlightenment: Are Attentional Gamma Oscillations Driven by ING or PING? , 2009, Neuron.

[68]  M. Nicolelis,et al.  Hyperdopaminergia and NMDA Receptor Hypofunction Disrupt Neural Phase Signaling , 2009, The Journal of Neuroscience.

[69]  E. Ginns,et al.  Molecular Determinants of Dysregulated GABAergic Gene Expression in the Prefrontal Cortex of Subjects with Schizophrenia , 2009, Biological Psychiatry.

[70]  Anthony A Grace,et al.  A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia , 2009, The Journal of Neuroscience.

[71]  Rita Zemankovics,et al.  Maintaining network activity in submerged hippocampal slices: importance of oxygen supply , 2009, The European journal of neuroscience.

[72]  Benjamin W. H. Lim,et al.  Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars , 2008, Proceedings of the National Academy of Sciences.

[73]  J. Ehmsen,et al.  Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior , 2008, Molecular Psychiatry.

[74]  Athar N. Malik,et al.  Activity-dependent regulation of inhibitory synapse development by Npas4 , 2008, Nature.

[75]  K. Sakimura,et al.  Serine racemase is predominantly localized in neurons in mouse brain , 2008, The Journal of comparative neurology.

[76]  H. M. Morris,et al.  Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. , 2008, Cerebral cortex.

[77]  H. M. Morris,et al.  Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia , 2008, Neurotoxicity Research.

[78]  H. Lipp,et al.  Early Auditory Sensory Processing Deficits in Mouse Mutants with Reduced NMDA Receptor Function , 2008, Neuropsychopharmacology.

[79]  A. Vaccarino,et al.  Evaluation of morphine analgesia and motor coordination in mice following cortex-specific knockout of the N-methyl-d-aspartate NR1-subunit , 2008, Neuroscience Letters.

[80]  H. M. Morris,et al.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.

[81]  Elliot S. Gershon,et al.  Allelic association of G72/G30 with schizophrenia and bipolar disorder: A comprehensive meta-analysis , 2008, Schizophrenia Research.

[82]  T. Deerinck,et al.  Regulation of spine morphology and spine density by NMDA receptor signaling in vivo , 2007, Proceedings of the National Academy of Sciences.

[83]  B. Moghaddam,et al.  NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons , 2007, The Journal of Neuroscience.

[84]  S. Noda,et al.  The serine racemase mRNA is predominantly expressed in rat brain neurons. , 2007, Archives of histology and cytology.

[85]  M. Matsushita,et al.  A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia , 2007, Biological Psychiatry.

[86]  R. Panizzutti,et al.  A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia , 2007, Schizophrenia Research.

[87]  J. Lieberman,et al.  Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction , 2006, Pharmacology Biochemistry and Behavior.

[88]  F. McMahon,et al.  G72/G30 in Schizophrenia and Bipolar Disorder: Review and Meta-analysis , 2006, Biological Psychiatry.

[89]  S. Oliet,et al.  Glia-Derived d-Serine Controls NMDA Receptor Activity and Synaptic Memory , 2006, Cell.

[90]  Elena Kartvelishvily,et al.  Neuron-derived D-Serine Release Provides a Novel Means to Activate N-Methyl-D-aspartate Receptors* , 2006, Journal of Biological Chemistry.

[91]  Sheryl S. Moy,et al.  Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function , 2006, Brain Research.

[92]  L. Abramova,et al.  Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia , 2006, Molecular Psychiatry.

[93]  Ramin V. Parsey,et al.  Altered Serotonin 1A Binding in Major Depression: A [carbonyl-C-11]WAY100635 Positron Emission Tomography Study , 2006, Biological Psychiatry.

[94]  Chih-Chiang Chiu,et al.  Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study. , 2005, Archives of general psychiatry.

[95]  R. Fradley,et al.  STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating , 2005, Behavioural Brain Research.

[96]  B. Kampa,et al.  Synaptic integration in dendritic trees. , 2005, Journal of neurobiology.

[97]  D. Lewis,et al.  Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.

[98]  Daniel C. Javitt,et al.  D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia , 2005, Biological Psychiatry.

[99]  J. Meier,et al.  GluR‐ and TrkB‐mediated maturation of GABAA receptor function during the period of eye opening , 2005, The European journal of neuroscience.

[100]  Dean V. Buonomano,et al.  Timing and Balance of Inhibition Enhance the Effect of Long-Term Potentiation on Cell Firing , 2004, The Journal of Neuroscience.

[101]  J. Lieberman,et al.  Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function , 2004, Behavioural Brain Research.

[102]  Robert F. Miller,et al.  D‐Serine as a glial modulator of nerve cells , 2004, Glia.

[103]  Jorge V. José,et al.  Inhibitory synchrony as a mechanism for attentional gain modulation , 2004, Journal of Physiology-Paris.

[104]  Bita Moghaddam,et al.  NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[105]  D. Lewis,et al.  Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction , 2004, Psychopharmacology.

[106]  J. Storm-Mathisen,et al.  GABAergic synapses in hippocampus exocytose aspartate on to NMDA receptors: quantitative immunogold evidence for co-transmission , 2004, Molecular and Cellular Neuroscience.

[107]  A. Sampson,et al.  Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.

[108]  D. Lorrain,et al.  Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 , 2003, Neuroscience.

[109]  R. Panizzutti,et al.  Neurobiology through the looking-glass: d-serine as a new glial-derived transmitter , 2002, Neurochemistry International.

[110]  E. Jodo,et al.  Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats , 2002, Neuroscience.

[111]  J. Lieberman,et al.  Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function , 2002, Brain Research.

[112]  P. Sham,et al.  Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[113]  F. Golley,et al.  Structure and Function , 2002, Science's STKE.

[114]  Fred H. Gage,et al.  Adeno-associated virus effectively mediates conditional gene modification in the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[115]  C. Tamminga,et al.  Effects of Ketamine in Normal and Schizophrenic Volunteers , 2001, Neuropsychopharmacology.

[116]  R. Gainetdinov,et al.  Genetic animal models: focus on schizophrenia , 2001, Trends in Neurosciences.

[117]  Susumu Tonegawa,et al.  Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex , 2000, Nature.

[118]  D. Linden,et al.  D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[119]  G. Rosoklija,et al.  Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. , 2000, Archives of general psychiatry.

[120]  M. Colonnese,et al.  Chronic NMDA exposure accelerates development of GABAergic inhibition in the superior colliculus. , 2000, Journal of neurophysiology.

[121]  M. Ekker,et al.  A Highly Conserved Enhancer in the Dlx5/Dlx6Intergenic Region is the Site of Cross-Regulatory Interactions betweenDlx Genes in the Embryonic Forebrain , 2000, The Journal of Neuroscience.

[122]  S H Snyder,et al.  Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[123]  J. Pierri,et al.  Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia , 1999, Biological Psychiatry.

[124]  Marc G Caron,et al.  Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.

[125]  Nicholas Lange,et al.  D-serine added to antipsychotics for the treatment of schizophrenia , 1998, Biological Psychiatry.

[126]  O. Paulsen,et al.  Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro , 1998, Nature.

[127]  J. Kauer,et al.  Properties of carbachol-induced oscillatory activity in rat hippocampus. , 1997, Journal of neurophysiology.

[128]  Anil K Malhotra,et al.  Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.

[129]  R. Roth,et al.  Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. , 1997, Science.

[130]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[131]  S. Snyder,et al.  d-Serine as a Neuromodulator: Regional and Developmental Localizations in Rat Brain Glia Resemble NMDA Receptors , 1997, The Journal of Neuroscience.

[132]  F. Vollenweider,et al.  Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) , 1997, European Neuropsychopharmacology.

[133]  S. Tonegawa,et al.  The Essential Role of Hippocampal CA1 NMDA Receptor–Dependent Synaptic Plasticity in Spatial Memory , 1996, Cell.

[134]  K. I. Blum,et al.  Impaired Hippocampal Representation of Space in CA1-Specific NMDAR1 Knockout Mice , 1996, Cell.

[135]  M. Hasselmo,et al.  NMDA-dependent modulation of CA1 local circuit inhibition , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[136]  Masahiko Watanabe,et al.  Impairment of Suckling Response, Trigeminal Neuronal Pattern Formation, and Hippocampal LTD in NMDA Receptor ε2 Subunit Mutant Mice , 1996, Neuron.

[137]  L. Benardo,et al.  Recruitment of GABAA inhibition in rat neocortex is limited and not NMDA dependent. , 1995, Journal of neurophysiology.

[138]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[139]  S. Snyder,et al.  D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[140]  D R Medoff,et al.  Ketamine activates psychosis and alters limbic blood flow in schizophrenia , 1995, Neuroreport.

[141]  E. Costa,et al.  Exposure of neuronal cultures to K+ depolarization or to N-methyl-d-aspartate increases the transcription of genes encoding the α1 and α 5 GABAA receptor subunits , 1995 .

[142]  J. Connor,et al.  Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death , 1994, Neuron.

[143]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[144]  Susumu Tonegawa,et al.  Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice , 1994, Cell.

[145]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[146]  H. Wigström,et al.  Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition , 1983, Nature.

[147]  J. Coyle,et al.  The Role of Serine Racemase in the Pathophysiology of Brain Disorders. , 2018, Advances in pharmacology.

[148]  A. Ivanov,et al.  Hippocampus In Vitro , 2017 .

[149]  M. van den Buuse Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. , 2010, Schizophrenia bulletin.

[150]  A. Ramsey NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia. , 2009, Progress in brain research.

[151]  P. Jonas,et al.  Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks , 2007, Nature Reviews Neuroscience.

[152]  Peter Jonas,et al.  Patch-clamp recording from mossy fiber terminals in hippocampal slices , 2006, Nature Protocols.

[153]  T. Sejnowski,et al.  Cholinergic induction of oscillations in the hippocampal slice in the slow (0.5–2 Hz), theta (5–12 Hz), and gamma (35–70 Hz) bands , 2000, Hippocampus.

[154]  A. Malhotra,et al.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. , 1997, The American journal of psychiatry.

[155]  W Singer,et al.  Visual feature integration and the temporal correlation hypothesis. , 1995, Annual review of neuroscience.

[156]  E. Costa,et al.  Exposure of neuronal cultures to K+ depolarization or to N-methyl-D-aspartate increases the transcription of genes encoding the alpha 1 and alpha 5 GABAA receptor subunits. , 1995, Brain Research. Molecular Brain Research.